Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study.

Munetaka Takekuma,Yasuyuki Hirashima,Kimihiko Ito,Hiroshi Tsubamoto,Tsutomu Tabata,Atsushi Arakawa,Yoshio Itani,Naoto Furukawa,Homare Murakoshi,Satoshi Takeuchi

Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: A Kansai Clinical Oncology Group study.

2011

Munetaka Takekuma
Yasuyuki Hirashima
Kimihiko Ito
Hiroshi Tsubamoto
Tsutomu Tabata
Atsushi Arakawa
Yoshio Itani
Naoto Furukawa
Homare Murakoshi
Satoshi Takeuchi

5102 Background: A multicenter phase II trial was conducted to evaluate the activity and toxicity of paclitaxel and nedaplatin (cis-diammineglycolatoplatonum) in patients with advanced/recurrent ut...

Keywords:

Nedaplatin
Clinical Oncology
Urology
Paclitaxel
Physical therapy
Gynecology
Cervical cancer
Medicine
Toxicity
Internal medicine
uterine cervical cancer
Oncology
group study
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations